WORLD MEDICAL ALLIANCE(THAILAND) CO., LTD. World Medical Alliance (Thailand) Company Limited (WMA), a securities issuer, had a duty to prepare and submit the financial statement for the year 2021

and related person as following details: Borrower Mana Patanakarn Company Limited as a subsidiary of Nawarat Patanakarn Public Company Limited (“the Company”) Lender 1. K Alliance Company Limited 2. Mrs

(MB) 83.9 209.3 -59.9% EBITDA (%) 9.6% 23.0% Earnings per share (Baht) 0.08 0.28 Remark : EBITDA = Profit before finance costs, income tax, Depreciation and Amortization Statement of Income : Million

% Net Profit 1.3% 6.7% EBITDA (MB) 9.0 20.8 -56.9% EBITDA (%) 5.1% 11.7% Earnings per share (Baht) - 0.02 -100.0% Remark : EBITDA = Profit before finance costs, income tax, Depreciation and Amortization

% 10.1% EBITDA (MB) 21.9 37.0 -40.8% EBITDA (%) 9.7% 18.0% Earnings per share (Baht) 0.02 0.04 -50.0% Remark : EBITDA = Profit before finance costs, income tax, Depreciation and Amortization Statement of

% 2.2% EBITDA (MB) 27.8 14.9 86.3% EBITDA (%) 14.6% 6.2% Earnings per share (Baht) 0.03 0.01 200.0% Remark : EBITDA = Profit before finance costs, income tax, Depreciation and Amortization Statement of

% Administrative expenses - 2.6 - 9.6 73.1% Finance costs - 4.5 - 3.1 -46.3% Profit for the period 28.4 17.2 64.7% Net Profit 10.3% 9.1% EBITDA (MB) 45.9 27.8 65.4% EBITDA (%) 16.6% 14.6% Earnings per share (Baht

person as following details: Borrower Mana Patanakarn Company Limited as a subsidiary of Nawarat Patanakarn Public Company Limited which 100% share holding Lender 1. K Alliance Company Limited 2. Mrs

Mrs. Siriya Thepcharoen Mrs. Siriya Thepcharoen, Chief Executive Officer who is responsible for the operation of World Medical Alliance (Thailand) Company Limited (WMA) shall be liable for WMA's

higher earnings from operations. 1.9 Profit Sharing for non-controlling interest of a subsidiary company On Oct 1’ 2010, the company sold partial investment in a subsidiary company to Japanese alliance